Dr Alison BlainResearch Associate
Email: alison.blain@ncl.ac.uk Telephone: +44 (0) 191 241 8833 Fax: +44 (0) 191 241 8666 Address: Institute of Genetic Medicine
Blain A, Greally E, Laval S, Blamire A, Straub V, MacGowan GA. Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy .
PLoS One 2013, 8 (2), e57260.
Greally E, Davison BJ, Blain A, Laval S, Blamire A, Straub V, MacGowan GA. Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy .
Journal of Cardiovascular Magnetic Resonance 2013, 15 , 4.
Blain AM, Straub VW. Delta-sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches .
Skeletal Muscle 2011, 1 (1), 13.
Jørgensen LH, Blain A, Greally E, Laval SH, Blamire AM, Davison BJ, Brinkmeier H, Macgowan GA, Schrøder HD, Bushby K, Straub V, Lochmüller H. Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle .
American Journal of Pathology 2011, 178 (1), 273-283.
Bauer R, Blain A, Greally E, Bushby K, Lochmuller H, Laval S, Straub V, MacGowan GA. Intolerance to beta-blockade in a mouse model of delta-sarcoglycan-deficient muscular dystrophy cardiomyopathy .
European Journal of Heart Failure 2010, 12 (11), 1163-1170.
Bauer R, Blain A, Greally E, Lochmuller H, Bushby K, MacGowan GA, Straub V. Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism .
Neuromuscular Disorders 2010, 20 (1), 21-28.
Bauer R, Straub V, Blain A, Bushby K, MacGowan GA. Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy .
European Journal of Heart Failure 2009, 11 (5), 463-471.
Bauer R, MacGowan GA, Blain A, Bushby K, Straub V. Steroid treatment causes deterioration of myocardial function in the δ-sarcoglycan-deficient mouse model for dilated cardiomyopathy .
Cardiovascular Research 2008, 79 (4), 652-661.
Blain A, Greally E, Laval S, Blamire A, MacGowan G, Straub V. Animal Models of Duchenne Muscular Dystrophy, with Special Reference to the mdx Mouse .
Biocybernetics and Biomedical Engineering 2012, 32 (4), 3-15.
Blain A, Greally E, MacGowan G, Laval S, Blamire A, Gillender K, Lochmuller H, Bushby K, Straub V. Beta-blocker/ACE-inhibitor combination treatment in mdx mice .
In: United Kingdom Neuromuscular Translational Research Conference . 2012, Newcastle upon Tyne, UK: Elsevier Ltd.
Greally E, Blain A, Blamire AM, MacGowan G, Laval SH, Straub V. Manganese enhanced MRI as a useful in vivo outcome measure in assessing skeletal muscle calcium uptake in mouse models of muscular dystrophy .
In: United Kingdom Neuromuscular Translational Research Conference . 2012, Newcastle upon Tyne, UK: Elsevier Ltd.
Greally E, Blain A, Blamire AM, MacGowan G, Laval SH, Straub V. Manganese enhanced MRI as an outcome measure in assessing skeletal muscle calcium uptake in muscular dystrophy mouse models .
In: 17th International Congress of the World Muscle Society (WMS) . 2012, Perth, Australia: Elsevier Ltd.
Blain AM, Greally E, Laval SH, Blamire A, Lochmuller H, Bushby K, MacGowan G, Straub VW. Manganese enhanced MRI (MEMRI) as an outcome measure for cardiac function in the mdx mouse .
In: Neuromuscular Disorders: 16th International Congress of the World Muscle Society . 2011, Algarve, Portugal: Elsevier Ltd.
